{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:17:25Z","timestamp":1788556645215,"version":"build-2803163510"},"reference-count":17,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.esmoop.2026.107773","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T19:39:38Z","timestamp":1782157178000},"page":"107773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sex-based differences in tolerability of developmental antibody-drug conjugates (ADCs) in non-small-cell lung cancer (NSCLC)"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6259-8234","authenticated-orcid":false,"given":"C.","family":"Parisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8083-4069","authenticated-orcid":false,"given":"M.","family":"Banini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3111-5067","authenticated-orcid":false,"given":"F.","family":"Mantuano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Aldea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4477-3633","authenticated-orcid":false,"given":"P.","family":"Abdayem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Derosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Frelaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lavaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gazzah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hollebecque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Massard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Besse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9462-875X","authenticated-orcid":false,"given":"J.","family":"Remon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9184-7199","authenticated-orcid":false,"given":"B.","family":"Pistilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Vaz-Luis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Planchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Barlesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.esmoop.2026.107773_bib1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.lungcan.2021.12.002","article-title":"Antibody-drug conjugates: a promising novel therapeutic approach in lung cancer","volume":"163","author":"Desai","year":"2022","journal-title":"Lung Cancer"},{"issue":"33","key":"10.1016\/j.esmoop.2026.107773_bib2","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1200\/JCO.2017.73.4186","article-title":"Re-evaluating eligibility criteria for oncology clinical trials: analysis of investigational new drug applications in 2015","volume":"35","author":"Jin","year":"2017","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2026.107773_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13045-025-01720-3","article-title":"Treatment-related adverse events of antibody drug-conjugates in clinical trials","volume":"18","author":"Tan","year":"2025","journal-title":"J Hematol Oncol"},{"issue":"12","key":"10.1016\/j.esmoop.2026.107773_bib4","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/annonc\/mdz414","article-title":"Gender medicine and oncology: report and consensus of an ESMO workshop","volume":"30","author":"Wagner","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.esmoop.2026.107773_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2025.08.2538","article-title":"1914P Sex differences in the tolerability to novel targeted therapies: insights from a French lung cancer data system","volume":"36","author":"Parisi","year":"2025","journal-title":"Ann Oncol"},{"issue":"10 suppl 1","key":"10.1016\/j.esmoop.2026.107773_bib6","article-title":"P1.17.21 Gender disparities in remote patient monitoring: analysis from 973 lung cancer patients treated across 42 sites in France and Belgium","volume":"20","author":"Parisi","year":"2025","journal-title":"J Thorac Oncol"},{"issue":"12","key":"10.1016\/j.esmoop.2026.107773_bib7","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.3390\/cancers15123111","article-title":"Sex differences in lung cancer","volume":"15","author":"May","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.esmoop.2026.107773_bib8","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1038\/s41467-024-46945-x","article-title":"Outcome differences by sex in oncology clinical trials","volume":"15","author":"Kammula","year":"2024","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.esmoop.2026.107773_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.105573","article-title":"Toxicity and efficacy of antibody-drug conjugates in advanced solid tumors: a retrospective single-center analysis of clinical trials","volume":"10","author":"Woodford","year":"2025","journal-title":"ESMO Open"},{"issue":"22","key":"10.1016\/j.esmoop.2026.107773_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/1759-7714.70178","article-title":"Treatment-related adverse events of antibody-drug conjugate monotherapy in non-small cell lung cancer: a systematic review and meta-analysis","volume":"16","author":"Li","year":"2025","journal-title":"Thorac Cancer"},{"issue":"1","key":"10.1016\/j.esmoop.2026.107773_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-15941-6","article-title":"Sex hormones regulate the sexual dimorphism of the lung resident immune milieu","volume":"15","author":"Belios","year":"2025","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.esmoop.2026.107773_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.104002","article-title":"Sex differences in the pharmacokinetics of anticancer drugs: a systematic review","volume":"9","author":"Delahousse","year":"2024","journal-title":"ESMO Open"},{"issue":"2","key":"10.1016\/j.esmoop.2026.107773_bib13","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00050-2017","article-title":"Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients","volume":"50","author":"Delaunay","year":"2017","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.esmoop.2026.107773_bib14","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/jnci\/djz094","article-title":"Sex-based heterogeneity in response to lung cancer immunotherapy: a systematic review and meta-analysis","volume":"111","author":"Conforti","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.esmoop.2026.107773_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cllc.2023.10.007","article-title":"Lung cancer in women: the past, present, and future","volume":"25","author":"Florez","year":"2024","journal-title":"Clin Lung Cancer"},{"issue":"13","key":"10.1016\/j.esmoop.2026.107773_bib16","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.21.02377","article-title":"Sex differences in risk of severe adverse events in patients receiving immunotherapy, targeted therapy, or chemotherapy in cancer clinical trials","volume":"40","author":"Unger","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.esmoop.2026.107773_bib17","article-title":"Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium","volume":"44","author":"Franzoi","year":"2024","journal-title":"Lancet Reg Health Eur"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926017151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702926017151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:21:23Z","timestamp":1784546483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702926017151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2059702926017151"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.107773","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex-based differences in tolerability of developmental antibody-drug conjugates (ADCs) in non-small-cell lung cancer (NSCLC)","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2026.107773","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"107773"}}